Lilly's Jardiance meets main goal of two diabetes trials - Reuters

Lilly's Jardiance meets main goal of two diabetes trials Reuters (Reuters) - Eli Lilly & Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1 diabetes. Jardiance, although not approved for type-1 diabetes, is approved for use in ... and more »

from diabetes - Google News